Key result
Serum SCUBE1 levels show no difference between ischemic chest pain patients and healthy controls.
Why the study?
Does SCUBE1 measurement have diagnostic value in patients presenting to the emergency department with angina pectoris?
Cross-Sectional (n=118)
No
Does SCUBE1 measurement have diagnostic value in patients presenting to the emergency department with angina pectoris?
Serum SCUBE1 levels do not have diagnostic value for differentiating ischemic chest pain etiologies in patients presenting to the emergency department.
Answers are grounded in this paper and cite their sources.
SCUBE1 measurement lacks diagnostic value for ischemic chest pain in the ED; leaves open its utility in prospective or other cardiovascular contexts.
Objective: The purpose of this study was to investigate the value of signal peptide-CUB-EGF domain-containing protein 1 (SCUBE1) in the diagnosis of angina pectoris in patients presenting to the emergency department.Material and Methods: This prospective research was planned as a cross-sectional, single-center clinical study. Patients presenting to the emergency department with angina pectoris symptoms over a period of five months from receipt of ethical committee approval were included. Patients presenting with ischemic chest pain were divided on the basis of etiology into stable angina pectoris (SAP), unstable angina pectoris (UAP), non-ST elevation myocardial infarction (NSTEMI), and ST segment elevation myocardial infarction (STEMI) groups. Clinical, laboratory and demographic characteristics were recorded. SCUBE1 levels from each group were compared with a healthy control group.Results: 118 individuals were enrolled in the study, 78 patients meeting the inclusion criteria and 40 healthy controls. Patients’ mean age was 54.36 ± 14.03 years, and 88.5% (n=69) were male. Hypertension (59%) and smoking (62%) predomination over other risk factors. NSTEMI was the most common factor (46.1%) in patients enrolled due to ischemic chest pain. No statistically significant difference was determined between patients’ serum SCUBE1 levels at time of presentation and at 6 h and 12 h and the control group (p>0.05).Conclusion: On the basis of our study findings, SCUBE1 is of no value in the diagnosis of ischemic chest pain etiologies.
No takes yet. Share an insight, caveat, or question.
Şahin et al. (2018) conducted a cross-sectional in Angina pectoris (n=118). Serum SCUBE1 levels vs. Healthy controls was evaluated on Serum SCUBE1 levels at time of presentation, 6 hours, and 12 hours (p=>0.05). Serum SCUBE1 levels did not significantly differ between patients presenting with ischemic chest pain and healthy controls at admission, 6 hours, or 12 hours.
Synapse has enriched 10 related papers. Consider them for comparative context: